The early data generated by pseudovirus testing of the full Omicron variant spike against the combination used in Evusheld provides preclinical evidence that it retains neutralizing activity against all tested variants of concern.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3m995HG
0 Comments